First administration in healthy volunteers of a single and increasing dose of a new molecule for the treatment of brain diseases
Phase 1
- Conditions
- Post-Traumatic Stress Disorder (PTSD)MedDRA version: 21.1Level: PTClassification code: 10036316Term: Post-traumatic stress disorder Class: 100000004873Therapeutic area: Psychiatry and Psychology [F] - Mental Disorders [F03]Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Registration Number
- CTIS2023-505030-99-00
- Lead Sponsor
- Rest Therapeutics
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- Male
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: ;Secondary Objective: ;Primary end point(s):
- Secondary Outcome Measures
Name Time Method